Migraine and the risk of dementia: a meta-analysis and systematic review

Aging Clin Exp Res. 2022 Jun;34(6):1237-1246. doi: 10.1007/s40520-021-02065-w. Epub 2022 Jan 31.

Abstract

Objectives: To conduct a comprehensive systematic review and meta-analysis to explore the correlation between migraine and the risk of dementia.

Methods: The PubMed, EMBASE, and Cochrane library databases were searched systematically. We selected cohort studies (prospective and retrospective) and case-control studies that reported migraine in patients with dementia, including vascular dementia. The pooled effects were analyzed to evaluate relative risk with 95% confidence intervals.

Results: In total, nine studies (two case-control and seven cohort studies) including 291,549 individuals were identified. These studies indicated that people with migraine (relative risk = 1.33; 95% confidence interval: 1.16-1.53) have an increased risk of all-cause dementia. Additionally, the pooled results of four studies showed that migraine is associated with an increased risk of vascular dementia (relative risk = 1.85; 95% confidence interval: 1.22-2.81; P = 0.004).

Conclusions: Data from observational studies suggest that migraine may be a risk factor for dementia, particularly vascular dementia. More studies are warranted to explore the association between migraine and dementia and the potential common pathophysiological mechanisms.

Keywords: Alzheimer’s disease; Dementia; Meta-analysis; Migraine; Vascular dementia.

Publication types

  • Meta-Analysis
  • Systematic Review

MeSH terms

  • Dementia, Vascular* / complications
  • Dementia, Vascular* / etiology
  • Humans
  • Migraine Disorders* / complications
  • Migraine Disorders* / epidemiology
  • Prospective Studies
  • Retrospective Studies
  • Risk Factors